By Kevin E. Noonan — On May 28th, Junior Party the Broad Institute, Harvard University, and MIT (collectively, “Broad”) filed its Substantive Preliminary Motion No. 3 in CRISPR Interference No. 106,126 (where ToolGen is the Senior Party). This motion, pursuant to 37 C.F.R. §§ 41.121(a)(1)(iii) and 41.208(a)(1) requested that the Board de-designate Broad claims in these five categories as not corresponding to either Count 1 or proposed Count 2 (A-E) or Count 1 (F): • Category A: use of vectors for RNA expression; • Category B: Staphylococcus aureusCas9 protein (“SaCas9”); • Category C: Cas9 chimeric CRISPR enzyme; • Category D:…
